| Schedule of Intangible Assets |
Intangible assets were as follows as of August 31, 2023 and November 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
Useful lives |
|
August 31, 2023 |
|
|
November 30, 2022 |
|
Patents |
|
10-20 years |
|
$ |
697,744 |
|
|
$ |
697,744 |
|
Less: Accumulated amortization |
|
|
|
|
(150,400 |
) |
|
|
(120,297 |
) |
License agreement |
|
10 years |
|
|
474,000 |
|
|
|
474,000 |
|
Less: Intangible asset impairment |
|
|
|
|
(185,000 |
) |
|
|
(185,000 |
) |
Less: Accumulated amortization |
|
|
|
|
(242,744 |
) |
|
|
(225,157 |
) |
Customer relationships – PrepaCyte®CB |
|
15 years |
|
|
41,000 |
|
|
|
41,000 |
|
Less: Intangible asset impairment |
|
|
|
|
(26,267 |
) |
|
|
(26,267 |
) |
Less: Accumulated amortization |
|
|
|
|
(9,307 |
) |
|
|
(8,711 |
) |
Brand |
|
1 year |
|
|
31,000 |
|
|
|
31,000 |
|
Less: Accumulated amortization |
|
|
|
|
(31,000 |
) |
|
|
(31,000 |
) |
Customer relationships – Cord:Use |
|
30 years |
|
|
960,000 |
|
|
|
960,000 |
|
Less: Accumulated amortization |
|
|
|
|
(168,000 |
) |
|
|
(144,000 |
) |
Net Intangible Assets |
|
|
|
$ |
1,391,026 |
|
|
$ |
1,463,312 |
|
|